In this study, we identified a fully human VH-based dAb, SMET2.1, which, as an Fc-fusion protein, specifically inhibited the proliferation of HER2-overexpressing human breast cancer cells but not gastric and ovarian cancer cells. This evidence concerns the gene ERBB2 and breast carcinoma.